My Account Log in

4 options

Building a national framework for the establishment of regulatory science for drug development : workshop summary / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs.

EBSCOhost Academic eBook Collection (North America) Available online

View online

Ebook Central Academic Complete Available online

View online

NCBI Bookshelf Available online

View online

National Academies Press Available online

View online
Format:
Book
Conference/Event
Author/Creator:
Institute of Medicine (U.S.).
Contributor:
Lebovitz, Yeonwoo.
English, Rebecca A.
Claiborne, Anne B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
Conference Name:
Building a National Framework for the Establishment of Regulatory Science for Drug Development (2010 : Washington, D.C.)
Language:
English
Subjects (All):
Pharmaceutical policy--United States--Congresses.
Pharmaceutical policy.
Drug development--Government policy--United States--Congresses.
Drug development.
Pharmaceutical industry--Government policy--United States--Congresses.
Pharmaceutical industry.
Physical Description:
1 online resource (95 pages)
Edition:
First edition.
Place of Publication:
Washington, D.C. : National Academies Press, 2011.
Language Note:
English
Summary:
"The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description.
Contents:
""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies""
Notes:
"Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy."
Includes bibliographical references.
ISBN:
0-309-20959-5
1-283-01910-8
9786613019103
0-309-15890-7
OCLC:
923283190

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Library Catalog Using Articles+ Library Account